Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis

• Published in: Journal of the Royal College of Surgeons of Edinburgh Vol. 47; no. 2; pp. 485 - 490
• Main Authors: KLIMOPOULOS, S, KATSOULIS, Ie, MARGELLOS, V, NIKOLOPOULOU, N
• Format: Journal Article
• Language: English
• Published: Edinburgh Royal College of Surgeons of Edinburgh 01.04.2002
• Subjects: Abdomen; Adolescent; Adult; Aged; Biological and medical sciences; Female; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Intestinal Obstruction - etiology; Intestinal Obstruction - surgery; Male; Medical sciences; Middle Aged; Other diseases. Semiology; Peritoneal Dialysis, Continuous Ambulatory - adverse effects; Peritonitis - etiology; Peritonitis - surgery; Retrospective Studies; Sclerosis; Tissue Adhesions - surgery; Kidney disease; Human; Urinary system disease; Continuous; Peritoneal dialysis; Sclerosis; Extrarenal dialysis; Treatment; Abdominal disease; Surgery; Debridment; Renal failure; Fibrosis; Complication; Peritonitis
• ISSN: 0035-8835; 1365-2877

Sclerosing peritonitis (SCP) is a complication of continuous ambulatory peritoneal dialysis (CAPD) and is characterized by progressive fibrosis of the peritoneum. Entrapment of the intestine in a fibrous sac resulting in complete intestinal obstruction is called sclerosing-encapsulating peritonitis (SEP) and represents the most severe form of the disease. Various reports have been pessimistic regarding the surgical outcome when SEP has caused complete intestinal obstruction. Continuation of CAPD after laparotomy is generally considered not feasible. The aim of this article is to present our experience in the surgical management of SEP and, in particular, in the postoperative continuation of CAPD. Seventeen consecutive patients with SCP among 175 patients undergoing CAPD during a period of 14 years in a single Unit were retrospectively reviewed. Two groups of patients were recognized. The SCP group included 9 patients with incomplete intestinal obstruction that were treated with single peritoneal catheter removal and switching to haemodialysis. The SEP group included 8 patients with complete obstruction that necessitated laparotomy for surgical debridement of the fibrotic tissue and release of the intestinal loops. Switching to haemodialysis improved the majority of the group of patients. In 2 of the SEP group of patients (early in the series), where enterectomy was inevitable, performance of an intestinal anastomosis resulted in leakage with subsequent fatal outcome. Two of the SEP group of patients were transferred to haemodialysis after the laparotomy. In the remaining 4 SEP patients (50%), exposure of a significant portion of active peritoneal surface was achieved - called "neoperitonization"-and allowed effective continuation of peritoneal dialysis for an average duration of 16 months (range 1-32). In patients with SEP, careful release of the intestinal loops avoiding enterectomies and even inadvertent intestinal wounds is mandatory. Continuation of peritoneal dialysis after meticulous debridement and removal of the fibrotic tissue is possible and may be effective. To the best of our knowledge, there have not been previously reported cases of continuations of CAPD after laparotomy for SEP.